Skip to main content
Caplight Logo









Unravel Health

Unravel Health

Private
LondonHealthcare & Life Scienceshttps://unravel.health/

Last Round

Grant

Feb 20, 2025

Total Funding Raised

$161,250

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Unravel Health is a health technology company that develops a non-invasive, at-home saliva monitoring device to track hormonal patterns and biomarkers for women's health.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Healthcare Analytics, Health IoT, D2C Brands, Sensors

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS, Data as a Service

AI Layer

Application

Keywords

femtechat-home hormone testingsaliva monitoringhormonal healthbiomarker trackingwomen's health techdiagnostic hardwarehealth IoTpersonalized health insightshormone analyticsPCOS managementperimenopause trackingdigital healthdata as a serviceDaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Unravel Health Comparables

Compare Unravel Health with similar companies based on industry and business-model similarity.

Unravel Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hormona
84%
Eli Health
84%
Mint Diagnostics
79%

Unravel Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 20, 2025
AcceleratorDec 3, 2024
AcceleratorOct 25, 2024

Unravel Health Investors

Notable investors and investment history

Unravel Health investors
InvestorRounds
STACAccelerator
University of GlasgowAccelerator
SBRI HealthcareGrant
Health Innovation NetworkGrant
NHS Accelerated Access CollaborativeGrant
Central Research LaboratoryAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 60% MoM.

  • Jun 20, 2026

    Monthly visitors increased 37% MoM.

Unravel Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Unravel Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Unravel Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range9
Year Founded2024
Last FundingFeb 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?